Gilead Sciences Inc (GILD)
65.75
+0.48
(+0.74%)
USD |
NASDAQ |
Apr 26, 15:00
Gilead Sciences Gross Profit (TTM): 20.62B for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 20.62B |
September 30, 2023 | 21.59B |
June 30, 2023 | 21.75B |
March 31, 2023 | 21.41B |
December 31, 2022 | 21.62B |
September 30, 2022 | 20.25B |
June 30, 2022 | 20.80B |
March 31, 2022 | 20.81B |
December 31, 2021 | 20.70B |
September 30, 2021 | 22.11B |
June 30, 2021 | 21.35B |
March 31, 2021 | 20.60B |
December 31, 2020 | 20.12B |
September 30, 2020 | 18.29B |
June 30, 2020 | 17.42B |
March 31, 2020 | 18.03B |
December 31, 2019 | 17.77B |
September 30, 2019 | 17.80B |
June 30, 2019 | 17.74B |
March 31, 2019 | 17.51B |
December 31, 2018 | 17.27B |
September 30, 2018 | 17.74B |
June 30, 2018 | 18.71B |
March 31, 2018 | 20.28B |
December 31, 2017 | 21.74B |
Date | Value |
---|---|
September 30, 2017 | 23.29B |
June 30, 2017 | 24.18B |
March 31, 2017 | 25.08B |
December 31, 2016 | 26.13B |
September 30, 2016 | 27.33B |
June 30, 2016 | 28.19B |
March 31, 2016 | 28.52B |
December 31, 2015 | 28.63B |
September 30, 2015 | 27.44B |
June 30, 2015 | 25.26B |
March 31, 2015 | 23.63B |
December 31, 2014 | 21.10B |
September 30, 2014 | 17.11B |
June 30, 2014 | 14.16B |
March 31, 2014 | 10.63B |
December 31, 2013 | 8.343B |
September 30, 2013 | 7.993B |
June 30, 2013 | 7.722B |
March 31, 2013 | 7.427B |
December 31, 2012 | 7.231B |
September 30, 2012 | 6.935B |
June 30, 2012 | 6.695B |
March 31, 2012 | 6.511B |
December 31, 2011 | 6.261B |
September 30, 2011 | 6.147B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
17.42B
Minimum
Jun 2020
22.11B
Maximum
Sep 2021
20.04B
Average
20.62B
Median
Dec 2023
Gross Profit (TTM) Benchmarks
Amgen Inc | 19.74B |
Johnson & Johnson | 61.53B |
Eli Lilly and Co | 27.04B |
Pfizer Inc | 33.54B |
CymaBay Therapeutics Inc (DELISTED) | -- |